Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 5

Cover image of 'Zoledronic acid for primary breast cancer'

Zoledronic acid for primary breast cancer (April 2019)

Breast Cancer Care

Zoledronic acid is a drug that’s given to reduce the risk of breast cancer spreading to the bones and other parts of the body. This booklet explains what it is, who might be offered it and the side effects it can cause.

Cover image of 'Zoledronic acid [Lithuanian]'

Zoledronic acid [Lithuanian] (December 2018)

Macmillan Cancer Support

Information from the Macmillan Cancer Support website translated into Lithuanian. Zoledronic acid is a bisphosphonate that can be used to help prevent bone loss, reduce the risk of cancer spreading to the bones in women with early breast cancer, treat bone weakness or pain caused by myeloma or cancer that has spread to the bones (secondary bone cancer), or treat high levels of calcium in the blood. This factsheet describes how it is given and the possible side-effects.

Cover image of 'ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients'

ATRA and anthracycline based therapy for acute myeloid leukaemia (AML). A guide for patients (March 2018)

Leukaemia Care

All-trans retinoic acid (ATRA), known as Tretinoin (Vesanoid®) is the acid form of vitamin A, which is used with chemotherapy for induction of remission in patients with confirmed acute promyelocytic leukaemia (APL), a subtype of acute myeloid leukaemia. This booklet describes the use of ATRA along with the chemotherapy drugs idarubicin and mitoxantrone.

Cover image of 'FOLFIRINOX'

FOLFIRINOX (May 2017)

Pancreatic Cancer UK

FOLFIRINOX is a possible treatment option for advanced pancreatic cancer. It is a combination of four drugs (leucovorin (folinic acid), fluorouracil, irinotecan and oxaliplatin). This factsheet describes how it is given and the possible side effects.

Cover image of 'A guide to life after oesophageal/gastric surgery - oesophagectomy and gastrectomy'

A guide to life after oesophageal/gastric surgery - oesophagectomy and gastrectomy (November 2017)

The Oesophageal Patients Association

This booklet has been written for people who have had an oesophagectomy or a gastrectomy. It describes the operation and recovery, how the surgery may affect eating and drinking, and the possible problems that may arise, such as dumping, gastric retention, acid regurgitation, or diarrhoea. It has advice on life after surgery; for example, driving, sleep, relationships, and going back to work, and concludes with suggestions for small meals, snacks and nutritious drinks.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm